351 Patents

Sl. No. Title Patent No Brand /Ingredient
1 Hypolipidemic effects of Bacillus coagulans US 11,213,553 LactoSpore®
2 Stable probiotic composition for the management of lactose intolerance US 11,202,810 LactoSpore®
3 Fructophilic lactic acid producing bacteria US 11,197,898 Fructospore®
4 Hair care compositions containing extracellular metabolite preparation from Bacillus coagulans US 11,123,382 LactoSporin®
5 Beverage compositions containing Bacillus coagulans MTCC 5856 US 11,052,125 LactoSpore®
6 Compositions for weight loss US 11,052,125 Cyperus + Forskolin + Garcinol
7 Composition for the therapeutic management of hypomelanotic skin conditions US 11,045,517 Forskolin + Nigellin®
8 Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 US 10,966,919 LactoSporin®
9 Bioactive molecules from Oroxylum indicum and their therapeutic applications US 10,959,980 Sabroxy®
10 Compositions containing thymohydroquinone and their method of preparation US 10,945,969 Nigellin®
11 Method of inhibiting propionibacterium acnes US 10,898,536 Artocarpus
12 Neuroprotective compositions and their use US 10,894,029 Sabroxy®
13 Compositions for the management of hyperglycemia and related conditions US 10,881,623 Nigellin®
14 Composition for prostaglandin transporter inhibition and related therapeutic applications US 10,864,243 Sabeet® + Nigellin® + Arjuna + SelenoForce®
15 Aphrodisiac composition and management of male sexual dysfunction US 10,864,242 Xxtrastrong
16 Skin care compositions and their applications US 10,864,154 Ethyl ascorbic acid + THC
17 Compositions and methods for reducing flatulence US 10,806,760 LactoSpore®
18 Composition for management of Helicobacter pylori infection US 10,792,295 LactoSpore® + Saberry®
19 Adaptogenic compositions and applications thereof US 10,716,823 Polybos + Saberry®
Polybos + Cococin
20 Stable probiotic composition containing Bacillus coagulans MTCC 5856 and method of detection thereof US 10,668,115 LactoSpore®
21 Liver protectant compositions and therapeutic applications US 10,653,643 LivLonga®
22 Beverage compositions containing Bacillus coagulans MTCC 5856 US 10,609,935 LactoSpore®
23 Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof US 10,588,844 Oletrip
24 Composition containing Oroxylin A and method of extraction thereof US 10,555,982 Oroxylin
25 Telomerase enhancement potential of Ecdysterone US 10,548,902 Ecdysterone
26 Functional nutritional blend for thermo-metabolic performance US 10,477,886 Metabolicgard
27 Process for the preparation of standardized composition of arjunoglucoside from the bark of Terminalia arjuna US 10,479,749 Arjunoglucoside
28 Process for the preparation of enantiopure 3-amino tetrahydrofuran and its salts US 10,421,734 3-Amino Tetrahydrofurans
29 Process for synthesis of Oroxylin A US 10,407,401 Sabroxy®
30 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof US 10,323,227 LactoSpore® + Starmeric
31 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof US 10,293,008 LactoSpore®
32 Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 US 10,260,112 LactoSpore®
33 Functional nutritional blend for thermo-metabolic performance US 10,258,073 Metabolicgard
34 Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof US 10,172,903 Cyperus
35 Bacillus coagulans MTCC 5856 for the management of major depressive disorder US 10,166,261 LactoSpore®
36 Process and compositions for achieving mammalian energy balance US 10,085,963 Forskolin
37 Oleanoyl peptide composition and skin hydration US 10,071,043 Olepent®
38 Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl) butadiene US 9,913,809 Zingiber cassumnar
39 Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl) butadiene US 9,833,422 Zingiber cassumnar
40 Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof US 9,782,450 Cyperus
41 Calebin A for hepatic steatosis US 9,737,502 Calebin
42 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof US 9,717,766 LactoSpore® + LactoCran
43 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof US 9,681,666 LactoSporin® + SabiLize®
44 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof US 9,681,665 LactoSporin®
45 Method for the treatment of hypercholesterolemia US 9,668,999 Calebin
46 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof US 9,635,862 LactoSporin®,
LactoSporin® + Sabilize®
47 Method for the treatment of hypercholesterolemia US 9,610,273 Calebin
48 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof US 9,596,861 LactoSporin®
49 Process for the therapeutic management of Diarrhea predominant irritable bowel syndrome using Bacillus coagulans US 9,579,352 LactoSpore®
50 Calebin A for osteoporosis US 9,539,232 Calebin
51 Synergistic selenopeptide formulations for the protection of dermal papilla cells US 9,498,423 Saberry® + Cococin + Se Peptide
52 Process for the manufacture of 3′-hydroxy pterostilbene US 9,458,075 3-hydroxypterostilbene
53 Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof US 9,387,193 Cyperus
54 Synthesis of Calebin A and its biologically active analogs US 9,365,486 Calebin
55 Anti-obesity potential of Calebin A US 9,328,330 Calebin
56 Composition and method for the protection of articular cartilage US 9,220,703 Calebin
57 Orally bioavailable stilbenoids-compositions and therapeutic applications thereof US 9,056,074 3-hydroxypterostilbene
58 Orally bioavailable stilbenoids-compositions and therapeutic applications thereof US 9,050,284 3-hydroxypterostilbene
59 Synthesis of 4-aryl 4-acyl piperidine, its salts and analogs using indium metal US 9,029,547 Pharmaceutical Intermediates
60 Orally bioavailable stilbenoids-compositions and therapeutic applications thereof US 9,029,424 3-hydroxypterostilbene
61 Oleanoyl peptide composition and method of treating skin aging US 8,987,212 Olepent®
62 Anti-obesity potential of Calebin A US 8,933,121 Calebin
63 Novel synthesis of 4-aryl 4-acyl piperidine, its salts and analogs using indium metal US 8,853,407 Pharmaceutical intermediates
64 Inotilone derivatives as coherent biological response modifier (cBMR) US 8,394,852 Inotilone derivatives
65 Peptides modified with triterpenoids and small organic molecules: synthesis and use in cosmeceuticals US 8,383,594 Olepent®
66 Compositions and its use in treating obesity or inducing weight loss US 8,329,743 Livinol+ Pterostilbene + Anthocyanin
67 Preservative system for cosmetic formulations—compositions and methods thereof US 8,329,095 SabiLize®
68 Protective compositions for dermal papilla cells US 8,247,003 Saberry® + Cococin
69 Dipeptides incorporating selenoamino acids with enhanced bioavailability–synthesis, pharmaceutical and cosmeceutical applications thereof US 8,193,156 LSM-Dipeptide Synthetic route
70 Treatment of superficial and cutaneous mycoses with a pure form of 1,7-bis(4-hydroxy-3-methoxyphe nyl)-3,5-heptanedione US 8,119,696 Tetrapure®
71 Dipeptides incorporating selenoaminoacids with enhanced bioavailability-synthesis US 8,003,614 MSC-Dipeptide Synthetic route
72 Hydro-alkoxyl citronellal compounds – synthetic routes, compositions and uses thereof US 7,842,842 Woody Odorants
73 Composition and methods for the management of hyperproliferative dermatological conditions US 7,582,314 Boswellin®
74 Novel non-cytotoxic synthetic analogues of (1E, 6E )-1,7-Bis (4 hydroxy-3-methoxyphenyl)-1,6-heptadiene-3, 5-dione and therapeutic applications thereof in cystic fibrosis US 7,521,580 Curcuminoid analogs
75 Processes for the manufacture of chiral and racemic forms of 3-aminotetrahydrofurans, their salts and derivatives US 7,514,573 3-Aminotetrahydrofurans
76 Convenient process of manufacture for Difluoromethylornithine and related compounds US 7,345,196 Efflornithine
77 Method of preparation and use of coconut water in mamalian tissue nourishment growth and healthy maintenance US 7,300,682 Cococin
78 Process for the synthesis of biologically active oxygenated compounds by dealkylation of the corresponding alkylethers US 7,253,324 Stilbenes
79 Commercially viable process for high purity of fatty alcohol C24 to C36 and its cosmetic application for skin hair and nails US 7,217,546 Policosanol
80 Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: Process for their manufacture and Uses US 7,202,270 Liposol®
81 Bioavailable composition of natural and synthetic HCA US 7,063,861 GarCitrin®
82 Compositions and methods containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation US 7,014,874 SelenoForce®
83 Convenient process of manufacture for Difluoromethylornithine and related compounds US 6,998,502 Efflornithine
84 Compositions and methods containing bioavailable Se-methyl-L-selenocysteine for human and veterinary use US 6,982,273 Methyselene® (MSC)
85 Process for preparing water soluble diterpenes and their applications US 6,960,300 Ocufors®
86 Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives US 6,849,645 Cosmoperine® (THP)
87 Manufacturing processes for Se-methyl-selenocysteine US 6,794,537 Methyselene® (MSC)
88 Process of obtaining compositions of stable lutein and lutein derivatives US 6,689,400 ZeaLutein®
89 Composition and methods containing an antimicrobial essential oil extracted from Coleus forskohlii US 6,607,712 Coleus Oil
90 Composition and method containing products extracted from commiphora sp. for prevention and treatment of abnormal cell growth and proliferation in inflammation, neoplasia and cardiovascular disease US 6,436,991 Gugulipid®
91 New Chemical entities with multiple modes of anti-inflammatory action US 7,378,442 AKBBA+NSAIDS
92 New chemical entities with multiple modes of anti-inflammatory action US 7,371,889 AKBBA+NSAIDS
93 Compositions and methods containing natural compounds from nonconventional sources that are useful in maintaining normal blood sugar levels US 7,160,562 Metformin-like compounds
94 Process for the production of potassium hydroxy citric acid, and compositions containing the potassium hydroxy citric acid US 6,770,782 Citrin® K
95 Cross regulin composition of turmeric-derived Tetrahydrocurcuminoids for skin lightening and protection against UVB rays US 6,653,327 Tetrahydrocurcuminoids
96 Process for making high purity piperine for nutritional use US 6,054,585 BioPerine®
97 Use of piperine as a bioavailability enhancer US 5,972,382 BioPerine®
98 Bioprotectant composition, method of use and extraction process of curcuminoids US 5,861,415 Curcumin C3 Complex®
99 Method of preparing a forskolin composition from forskolin extract and use of forskolin for promoting lean body mass and treating mood disorders US 5,804,596 ForsLean®
100 Potassium hydroxycitrate for the suppression of appetite and induction of weight loss US 5,783,603 Citrin® K
101 Use of piperine as a bioavailability enhancer US 5,744,161 BioPerine®
102 Use of piperine to increase bioavailability of nutritional compounds US 5,536,506 BioPerine®
Sl. No. Title Patent No Brand /Ingredient
1 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa Australia
AU2006235807
Curcumin C3 Reduct®
2 Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 Australia
AU2018282252
LactoSporin®
3 Enzyme composition for therapeutic management of muscle soreness Australia
AU2016428484
DigeZyme®
4 Bacillus coagulans MTCC 5856 for the management of major depressive disorder Australia
AU2016413572
LactoSpore®
5 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Australia
AU2015394033
Cyperus
6 Oleanoyl peptide compositions and collagen enhancement Australia
AU2015381703
Olepent®
7 Bioavailable composition of natural and synthetic HCA Australia
AU773081
GarCitrin®
8 Compositions and methods for the management of hyperproliferative dermatological conditions Australia
AU2004322710
Boswellin®
9 Compositions containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation Australia
AU2006321973
SelenoForce®
10 Process for preparing water soluble diterpenes and their applications Australia
AU2004272005
Ocufors®
11 Anti-obesity potential of Calebin A Australia
AU2012366253
Calebin
12 Hepatoprotectant activity of garcinol Australia
AU2011352073
Livinol
13 Composition for down-regulating pro-inflammatory markers Australia
AU2011200854
Boswellin® PS
14 Protective compositions for dermal papilla cells Australia
AU2010326651
Saberry® + Cococin
15 Oleanoyl peptide composition and a method of treating skin aging Australia
AU2011265587
Olepent®
16 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Australia
AU2014369819
LactoSporin®
17 Method for the treatment of hypercholesterolemia Australia
AU2014202312
Calebin
18 Synergistic selenopeptide formulations for the protection of dermal papilla cells Australia
AU2012203148
Saberry® + Cococin+ Se Peptide
19 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Australia
AU2015308650
LactoSpore®
20 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Australia
AU2013292593
Cyperus
21 Composition and method for the protection of articular cartilage Australia
AU2014201769
Calebin
22 Anti-obesity potential of Calebin A Australia
AU2014203122
Calebin
23 Process and compositions for achieving mammalian energy balance Australia
AU2015351423
Forskolin
24 3Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl) butadiene Australia
AU2016385393
Zingiber cassumnar
25 Synthesis of Calebin A and its biologically active analogs Australia
AU2014203764
Calebin
26 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Australia
AU2017228561
LactoSporin®
27 Use of piperine as a bioavailability enhancer Canada
CA2247467
BioPerine®
28 Forskolin for promoting lean body mass Canada
CA2281562
ForsLean®
29 Novel method for extraction of Oxyresveratrol from Artocarpus hirsutus Canada
CA3047702
Artocarpus hirsutus
30 Composition containing Oroxylin A and method of extraction thereof Canada
CA3043168
Sabroxy®
31 Natural molecules from Artocarpus hirsutus: Method of isolation and anti-acne potential thereof Canada
CA3047701
Artocarpus hirsutus
32 Natural molecules from Artocarpus hirsutus: Method of isolation and anti-acne potential thereof Canada
CA3047701
Artocarpus hirsutus
33 Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 Canada
CA2999517
LactoSpore®
34 Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Canada
CA2883176
Cyperus
35 Process for preparing water-soluble medicaments comprising complexation of forskolin in cyclodextrins Canada
CA2537820
Ocufors®
36 Anti-obesity Potential of Calebin A Canada
CA2857543
Calebin
37 Composition for down-regulating pro-inflammatory markers Canada
CA2732915
Boswellin® PS
38 Hepatoprotectant activity of garcinol Canada
CA2851663
Livinol
39 Synergistic selenopeptide formulations for the protection of dermal papilla cells Canada
CA2872535
Saberry® + Cococin+ Se Peptide
40 Method for the treatment of hypercholesterolemia Canada
CA2850999
Calebin
41 Synthesis of Calebin A and its biologically active analogs Canada
CA2858126
Calebin
42 Calebin A for hepatic steatosis Canada
CA2893321
Calebin
43 Composition and method for the protection of articular cartilage Canada
CA2935898
Calebin
44 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Canada
CA2899511
LactoSporin®,
LactoSporin® + Sabilize®
45 Method for the treatment of hypercholesterolemia Canada
CA2963383
Calebin
46 Calebin A for osteoporosis Canada
CA2941050
Calebin
47 Oleanoyl peptide composition and collagen enhancement Canada
CA2975170
Olepent®
48 Method to solubilize curcuminoids in water Canada
CA2976689
uC3 CLEAR®
49 Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl)butadiene Canada
CA2979287
Zingiber cassumnar
50 Method for the treatment of hypercholesterolemia Taiwan
I622384
Calebin
51 Composition for down-regulating pro-inflammatory markers Taiwan
I-434696
Boswellin® PS
52 Method of solubilising forskolin and isoforskolin in water and clear aqueous solution comprising the same Vietnam
12717
Ocufors®
53 Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives Germany
DE10196213
Cosmoperine®
54 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Hong kong
HK1232483
Cyperus
55 Process and compositions for achieving mammalian energy balance Hong kong
HK1238675
Forskolin
56 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Hong kong
HK1233174
LactoSpore®
57 Synthesis of Calebin A and its biologically active analogs Hong kong
HK1217689
Calebin
58 Process for preparing water soluble diterpenes and their applications Hong kong
HK1098450
Ocufors®
59 Method for the treatment of hypercholesterolemia Hong kong
HK1210590
Calebin
60 Synergistic selenopeptide formulations for the protection of dermal papilla cells Hong kong
HK1193758
Saberry®+ Cococin + Se Peptide
61 Calebin A for articular cartilage Hong kong
HK1210028
Calebin
62 Calebin A for use in the treatment of Inflammation and obesity Hong kong
HK1190874
Calebin
63 Process and compositions for achieving mammalian energy balance China
ZL201580083933.4
Forskolin
64 Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 China
ZL201680008035.7
LactoSpore®
65 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof China
ZL201580042813.X
LactoSpore®
66 Process For Preparing Water Soluble Diterpenes And Their Applications China
ZL200480028804.7
Ocufors®
67 Compositions and methods for the management of hyperproliferative dermatological conditions China
ZL200480043675.9
Boswellin®
68 Anti-obesity potential of Calebin A China
ZL201280012577.3
Calebin
69 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof China
ZL201480010615.0
LactoSporin®,
LactoSporin® + Sabilize®
70 Melanogenesis inhibition by 3,5-dimethoxy-4′-hydroxypterostilbenes and cosmeceutical applications thereof DPR Korea
1011504
PteroWhite®
71 Use of piperine as a bioavailability enhancer Europe
EP0810868
BioPerine®
72 Bioprotectant composition, method of use and extraction process of curcuminoids Europe
EP0839037
Curcumin C3 Complex®
73 Forskolin for promoting lean body mass Europe
EP0977564
ForsLean®
74 Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 Europe
EP3356545
LactoSpore®
75 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Europe
EP3291805
Cyperus
76/td>

Coconut water and its method of preparation Europe
EP1341547
Cococin
77 Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells Europe
EP1328263
Curcumin C3 Reduct®
78 Bioavailable composition of natural and synthetic HCA Europe
EP1254209
Garcitrin®
79 Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 Europe
EP3240553
LactoSpore®
80 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa Europe
EP1171144
Curcumin C3 Reduct®
81 Compositions containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation Europe
EP1968620
SelenoForce®
82 Process for preparing water soluble diterpenes and their applications Europe
EP1718568
Ocufors®
83 Compositions and methods for the management of hyperproliferative dermatological conditions Europe
EP1791423
Boswellin®
84 Hepatoprotectant activity of garcinol Europe
EP2658374
Livinol
85 Protective compositions for dermal papilla cells Europe
EP2461786
Saberry® + Cococin
86 Method for the treatment of hypercholesterolemia Europe
EP2937084
Calebin
87 Calebin A for use in the treatment of inflammation and obesity Europe
EP2663185
Calebin
88 Synergistic selenopeptide formulations for the protection of dermal papilla cells Europe
EP2695603
Saberry® + Cococin + Se Peptide
89 Composition and method for the protection of articular cartilage Europe
EP2893926
Calebin
90 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Europe
EP2989197
LactoSporin®
91 Calebin A for inducing lipolysis Europe
EP3085370
Calebin
92 Synthesis of Calebin A and its biologically active analogs Europe
EP2963007
Calebin
93 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Europe
EP2744571
Cyperus
94 Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Europe
EP3108935
Cyperus
95 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Europe
EP3185877
LactoSpore®
96 Process and composition for achieving mammalian energy balance Europe
EP3194575
Forskolin
97 Skin care compositions and their applications India
IN356811
Ethyl Asccorbic acid + Sabiwhite®
98 A method for solubilizing forskolin and a composition thereof India
IN235492
Ocufors®
99 A Process of preparing a synergistic composition for treating hyperproliferative dermatological condition India
IN238950
Boswellin®
100 A process for obtaining high purity fatty alcohols India
IN229695
Policosanol
101 Compositions and methods for reducing flatulence Japan
JP6987888
LactoSpore®
102 Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof Japan
JP6979518
Oletrip
103 Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 Japan
JP6938479
LactoSpore®
104 Use of Piperine as a bioavailability enhancer Japan
JP3953513
BioPerine®
105 Novel method for extraction of Oxyresveratrol from Artocarpus hirsutus Japan
JP6920462
Artocarpus hirsutus
106 Skin care applications of extracellular metabolites from Bacillus coagulans Japan
JP6918988
LactoSporin®
107 Bacillus coagulans MTCC 5856 for the management of major depressive disorder Japan
JP6908633
LactoSpore®
108 Natural molecules from Artocarpus hirsutus: Method of isolation and anti-acne potential thereof Japan
JP6896885
Artocarpus hirsutus
109 Enzyme composition for therapeutic management of muscle soreness Japan
JP6857240
DigeZyme®
110 Composition containing Oroxylin A and method of extraction thereof Japan
JP6851476
Sabroxy®
111 Composition for management of Helicobacter pylori infection Japan
JP6839329
LactoSpore® + Saberry®
112 Neuroprotective compositions and their use Japan
JP6796217
Sabroxy®
113 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Japan
JP6759243
Cyperus
114 Process of obtaining compositions of stable Lutein and Lutein derivatives Japan
JP4227409
Xenogard®
115 Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives Japan
JP4098985
Cosmoperine®
116 Bio-available compositions of natural and synthetic HCA Japan
JP4205943
GarCitrin®
117 Compositions and methods for the management of hyper-proliferative dermatological conditions Japan
JP4820819
Boswellin®
118 Process for preparing water soluble diterpenes and their applications Japan
JP5021305
Ocufors®
119 Hepatoprotectant activity of garcinol Japan
JP5980228
Livinol
120 Synergistic selenopeptide formulations for the protection of dermal papilla cells Japan
JP6064274
Saberry® + Cococin + Se Peptide
121 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Japan
JP6126307
LactoSporin®,
LactoSporin® + Sabilize®
122 Scirpusin A and Scirpusin B and anti-obesity potential thereof Japan
JP6135761
Cyperus
123 Composition and method for the protection of articular cartilage Japan
JP6142446
Calebin
124 Calebin A for hepatic steatosis Japan
JP6336943
Calebin
125 Oleanoyl peptide composition and a method of treating skin aging Japan
JP6176893
Olepent®
126 Method for the treatment of hypercholesterolemia Japan
JP6263707
Calebin
127 Anti-obesity potential of Calebin A Japan
JP6374716
Calebin
128 Process and compositions for achieving mammalian energy balance Japan
JP6472453
Forskolin
129 Synthesis of Calebin A and its biologically active analogs Japan
JP6490927
Calebin
130 Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl)butadiene Japan
JP6584526
Zingiber cassumnar
131 Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 Japan
JP6629875
LactoSpore®
132 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Japan
JP6630723
LactoSpore®
133 Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 Mexico
MX384468
LactoSpore®
134 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Mexico
MX376004
LactoSpore®
135 Process for preparing water soluble diterpenes and their applications Mexico
MX260326
Ocufors®
136 Composition for down-regulating pro-inflammatory markers Mexico
MX328842
Boswellin® PS
137 Synergistic selenopeptide formulations for the protection of dermal papilla cells Mexico
MX355546
Saberry® + Cococin +Se Peptide
138 Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 Malaysia
MY-185340-A
LactoSpore®
139 Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 Malaysia
MY-182658-A
LactoSpore®
140 Calebin A for hepatic steatosis Malaysia
MY-182000-A
Calebin
141 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Malaysia
MY-181102-A
LactoSporin®
142 Compositions and method for the protection of articular cartilage Malaysia
MY-175867-A
Calebin
143 Synergistic selenopeptide formulations for the protection of dermal papilla cells Malaysia
MY-168089-A
Saberry® + Cococin +Se Peptide
144 Method for the treatment of hypercholesterolemia Malaysia
MY-170067-A
Calebin
145 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Malaysia
MY-174855-A
LactoSpore®
146 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Newzealand
NZ748360
LactoSpore®®
147 Bacillus coagulans MTCC 5856 for the management of major depressive disorder Newzealand
NZ748553
LactoSpore®
148 Composition containing Oroxylin A and method of extraction thereof Newzealand
NZ753943
Sabroxy®
149 Enzyme composition for therapeutic management of muscle soreness Newzealand
NZ752952
DigeZyme®
150 Composition for physiological increase of male and female hormones with diterpene forskolin and its derivatives Newzealand
NZ552997
Forskolin
151 Compositions and methods for the management of hyperproliferative dermatological conditions Newzealand
NZ552027
Boswellin®
152 Commercial process for making forskolin and its derivatives Newzealand
NZ568652
Ocufors®
153 Process for preparing water soluble diterpenes and their applications Newzealand
NZ545765
Ocufors®
154 Bioavailable composition of natural and synthetic HCA Newzealand
NZ518116
GarCitrin®
155 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa Newzealand
NZ514884
Curcumin C3 Reduct®
156 Compositions containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation Newzealand
NZ568233
SelenoForce®
157 Protective compositions for dermal papilla cells Newzealand
NZ598630
Saberry®+ Cococin
158 Synergistic selenopeptide formulations for the protection of dermal papilla cells Newzealand
NZ600307
Saberry®+ Cococin + Se dipeptide
159 Method for the treatment of hypercholesterolemia Newzealand
NZ624269
Calebin
160 Hepatoprotectant activity of garcinol Newzealand
NZ609878
Livinol
161 Anti-obesity potential of Calebin A Newzealand
NZ614076
Calebin
162 Synthesis of Calebin A and its biologically active analogs Newzealand
NZ627247
Calebin
163 Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Newzealand
NZ622927
Cyperus
164 Anti-obesity potential of calebin A Newzealand
NZ715053
Calebin
165 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Newzealand
NZ711345
LactoSporin®,
LactoSporin® + Sabilize®
166 Composition and method for the protection of articular cartilage Newzealand
NZ622909
Calebin
167 Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl)butadiene Newzealand
NZ735027
Zingiber cassumnar
168 Method to solubilize curcuminoids in water Newzealand
NZ734491
UC3 clear®
169 Process and compositions for achieving mammalian energy balance Newzealand
NZ720422
Forskolin
170 Anti-pollution compositions containing Bacillus coagulans Russia
RU2745755
LactoSpore®
171 Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof Russia
RU2733372
Oletrip
172 Compositions and methods for the management of hyperproliferative dermatological conditions Russia
RU2366412
Boswellin®
173 Anti-obesity potential of Calebin A Russia
RU2543334
Calebin
174 Hepatoprotectant activity of garcinol Russia
RU2585245
Livinol
175 Synergistic selenopeptide formulations for the protection of dermal papilla cells Russia
RU2606752
Saberry® + Cococin + Se Peptide
176 Calebin A for hepatic steatosis Russia
RU2643297
Calebin
177 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Russia
RU2617965
LactoSporin®,
LactoSporin® + Sabilize®
178 Calebin A for osteoporosis Russia
RU2653103
Calebin
179 Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl)butadiene Russia
RU2694053
Zingiber cassumnar
180/td>

Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Russia
RU2691404
Cyperus
181 Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl)butadiene Singapore
SG11201707112P
Zingiber cassumnar
182 Process and compositions for achieving mammalian energy balance Singapore
SG11201801873T
Forskolin
183 Process for preparing water soluble diterpenes and their applications Singapore
SG121197
Ocufors®
184 Compositions and methods for the management of hyperproliferative dermatological conditions Singapore
SG136165
Boswellin®
185 Calebin A for hepatic steatosis Singapore
SG10201503805X
Calebin
186 Composition and methods for the protection of articular cartilage Singapore
SG11201605336Y
Calebin
187 Anti-obesity potential of calebin A Singapore
SG192695
Calebin
188 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Singapore
SG11201505628P
LactoSporin®,
LactoSporin® + Sabilize®
189 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Singapore
SG11201700006U
LactoSpore®
190 Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Singapore
SG11201707106U
Cyperus
191 Modulation of immune function by Bacillus coagulans South Africa
ZA2020/07348
Immunospore
192 Skin care compositions and their applications South Africa
ZA2020/06708
Ethyl Ascorbic Acid + SabiWhite®
193 Compositions for the management of hyperglycemia and related conditions South Africa
ZA2020/04532
Nigellin®
194 Bacillus coagulans MTCC 5856 for the management of major depressive disorder South Africa
ZA2019/00501
LactoSpore®
195 Enzyme composition for maintenance of metabolic health South Africa
2019/07676
DigeZyme®
196 Composition and methods for the management of hyperproliferative dermatological Conditions South Africa
ZA2007/0694
Boswellin®
197 Process for preparing water soluble diterpenes and their applications South Africa
ZA2006/01898
Ocufors®
198 Anti-obesity potential of Calebin A South Africa
ZA2013/05918
Calebin
199 Method to solubilize curcuminoids in water South Africa
ZA2017/06503
UC3 Clear®
200 Enzyme composition for therapeutic management of muscle soreness South Africa
ZA2019/02715
DigeZyme®
201 Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives Great Britain
GB2380675
Cosmoperine®
202 Process for preparing water soluble diterpenes and their application Uzbekistan
4028
Ocufors®
203 Process and composition for achieving mammalian energy balance Eurasia
EA38685
Forskolin
204 Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus Coagulans SBC37-01, MTCC 5856 Eurasia
EA037312
LactoSpore®
205 Process for preparing water soluble diterpenes and their applications Eurasia
EA012836
Ocufors®
206 Bacillus coagulans MTCC 5856 for the management of major depressive disorder Eurasia
EA038255
LactoSpore®
207 Protective compositions for dermal papilla cells Eurasia
EA20368
Saberry® + Cococin
208 Use of a composition for down-regulating/inhibiting PGE2 Eurasia
EA023717
Boswellin® PS
209 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Eurasia
EA025578
Cyperus
210 Method for the treatment of hypercholesterolemia Eurasia
EA027148
Calebin
211 Use of calebin A to protect mammalian articular cartilage from pathological damage Eurasia
EA027614
Calebin
212 Synthesis of calebin A and its biologically active analogs Eurasia
EA027726
Calebin
213 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Eurasia
EA034017
LactoSpore®
214 Oleanoyl peptide composition and collagen enhancement Eurasia
EA03512
Olepent®
215 Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus Coagulans SBC37-01, MTCC 585Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus Coagulans SBC37-01, MTCC 5856 Philippines
PH1-2017-50132
LactoSpore®
216 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Philippines
PH1-2017-500059
LactoSpore®
217 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Philippines
PH1-2015-500349
Cyperus
218 Process for preparing water soluble diterpenes and their applications Philippines
PH1-2006-500481
Ocufors®
219 Method for the treatment of hypercholesterolemia Philippines
PH1-2014-000244
Calebin
220 Calebin A for hepatic steatosis Philippines
PH1-2015-000188
Calebin
221 Composition and method for the protection of articular cartilage Philippines
PH1-2016-501138
Calebin
222 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Philippines
PH1-2015-502025
LactoSporin®,
LactoSporin® + Sabilize®
223 Skin care applications of extracellular metabolites from Bacillus coagulans Republic of Korea
KR10-2296051
LactoSporin®
224 Anti-obesity potential of garcinol Republic of Korea
KR10-2289324
Garcinol
225 Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 Republic of Korea
KR10-2288904
LactoSporin®
226 Hair care compositions containing extracellular metabolite preparation from Bacillus coagulans Republic of Korea
KR10-2288897
LactoSporin®
227 Process and compositions for achieving mammalian energy balance Republic of Korea
KR10-2169620
Forskolin
228 Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus Coagulans SBC37-01, MTCC 5856 Republic of Korea
KR10-2157043
LactoSpore®
229 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Republic of Korea
KR10-1600212
Cyperus
230 Synthesis of Calebin A and its biologically active analogs Republic of Korea
KR10-1629561
Calebin
231 Method for the treatment of hypercholesterolemia Republic of Korea
KR10-1647549
Calebin
232 Composition and method for the protection of articular cartilage Republic of Korea
KR10-1685263
Calebin
233 Composition and method for the protection of articular cartilage Republic of Korea
KR10-1685333
Calebin
234 Anti-obesity potential of Calebin A Republic of Korea
KR10-1702702
Calebin
235 Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Republic of Korea
KR10-1717889
Cyperus
236 Calebin A for hepatic steatosis Republic of Korea
KR10-1763474
Calebin
237 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Republic of Korea
KR 10-1770902
LactoSporin®,
LactoSporin® + Sabilize®
238 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Republic of Korea
KR10-2089566
LactoSpore®
239 Oleanoyl peptide composition and collagen enhancement Indonesia
IDP000074771
Olepent®
240 Novel pcr primers and methods thereof for the identification of Bacillus coagulans Indonesia
IDP000074645
LactoSpore®
241 Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Indonesia
PID201708495
Cyperus
242 Process and compositions for achieving mammalian energy balance Indonesia
IDP000071226
ForsLean®
243 Calebin A for hepatic steatosis Indonesia
IDP000067993
Calebin
244 Synergistic selenopeptide formulations for the protection of dermal papilla cell Indonesia
IDP000051688
Saberry® + Cococin + Se-dipeptide
245 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Indonesia
IDP00201506134
LactoSporin®,
LactoSporin® + Sabilize®
246 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Indonesia
IDP000062703
Cyperus
247 Calebin A and its effect on hypercholesterolemia Indonesia
IDP000064827
Calebin
248 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Indonesia
IDP000066793
LactoSpore®
249 Compositions and methods for the management of hyperproliferative dermatological conditions United Arab Emirates
AE3178
Boswellin®
  • Active
  • Expired
top